ANVS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Annovis Bio Inc (ANVS) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock lacks significant positive catalysts, has weak financial performance, and shows no clear technical or trading signals to suggest a compelling entry point. A hold is recommended until stronger indicators emerge.
The MACD is positive and expanding, indicating a slight bullish momentum. RSI is neutral at 65.041, and moving averages are converging, showing no clear trend. The stock is trading near its pivot level of 2.601, with resistance at 2.876 and support at 2.326. Overall, the technical indicators do not strongly favor a buy.
NULL identified. No recent news, no significant hedge fund or insider activity, and no congress trading data.
Weak financial performance with a significant drop in net income (-42.53% YoY) and EPS (-61.86% YoY). The stock also experienced a regular market decline of -3.82% and a post-market decline of -2.89%.
In Q3 2025, the company reported no revenue growth (0% YoY). Net income dropped significantly to -7,262,658 (-42.53% YoY), and EPS fell to -0.37 (-61.86% YoY). Gross margin remained at 0%. Overall, the financial performance is weak.
No data available for analyst ratings or price target changes.
